(CCEP) Coca-Cola European Partners - Overview
Sector: Consumer Defensive | Industry: Beverages - Non-Alcoholic | Exchange: NASDAQ (USA) | Market Cap: 39.567m USD | Total Return: 8% in 12m
Avg Turnover: 160M
EPS Trend: -34.8%
Qual. Beats: 0
Rev. Trend: 96.0%
Qual. Beats: 0
Warnings
Choppy
Tailwinds
No distinct edge detected
Coca-Cola Europacific Partners PLC (CCEP) is the world’s largest independent Coca-Cola bottler by revenue, operating across Europe, Australia, the Pacific, and Indonesia. The company manages the end-to-end supply chain, including the production, distribution, and marketing of an extensive portfolio that spans traditional soft drinks, energy drinks, water, and ready-to-drink alcoholic beverages.
The business model relies on a franchise system where CCEP purchases concentrate from The Coca-Cola Company and other brand owners to manufacture and sell finished products in exclusive territories. This capital-intensive model benefits from significant economies of scale and high barriers to entry within the consumer staples sector. Further insights into the companys long-term growth drivers are available on ValueRay.
Historically focused on Western Europe, the firm expanded its geographic footprint and market reach significantly following the 2021 acquisition of Coca-Cola Amatil. This strategic pivot transformed the entity into a multi-continental operation, diversifying its exposure across both mature and emerging beverage markets.
- Synergies from Asia-Pacific market integration drive long term revenue growth targets
- Fluctuating sugar taxes and environmental packaging regulations impact operating margins
- Input cost volatility for aluminum and PET plastics affects bottom line results
- Success of alcoholic and energy drink diversification shifts total brand valuation
- Consumer spending power in European markets dictates volume and premiumization trends
| Net Income: 3.36b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 8.42 > 1.0 |
| NWC/Revenue: -3.64% < 20% (prev -2.11%; Δ -1.53% < -1%) |
| CFO/TA 0.20 > 3% & CFO 5.98b > Net Income 3.36b |
| Net Debt (10.5b) to EBITDA (6.67b): 1.58 < 3 |
| Current Ratio: 0.80 > 1.5 & < 3 |
| Outstanding Shares: last quarter (449.1m) vs 12m ago -2.37% < -2% |
| Gross Margin: 35.61% > 18% (prev 0.37%; Δ 3.52k% > 0.5%) |
| Asset Turnover: 139.8% > 50% (prev 108.8%; Δ 31.03% > 0%) |
| Interest Coverage Ratio: 10.52 > 6 (EBITDA TTM 6.67b / Interest Expense TTM 512.7m) |
| A: -0.05 (Total Current Assets 6.08b - Total Current Liabilities 7.58b) / Total Assets 29.9b |
| B: 0.30 (Retained Earnings 8.82b / Total Assets 29.9b) |
| C: 0.18 (EBIT TTM 5.39b / Avg Total Assets 29.6b) |
| D: 0.35 (Book Value of Equity 7.53b / Total Liabilities 21.6b) |
| Altman-Z'' = 2.22 = BBB |
| DSRI: 0.75 (Receivables 2.78b/2.85b, Revenue 41.3b/31.8b) |
| GMI: 1.03 (GM 35.61% / 36.51%) |
| AQI: 1.00 (AQ_t 0.59 / AQ_t-1 0.59) |
| SGI: 1.30 (Revenue 41.3b / 31.8b) |
| TATA: -0.09 (NI 3.36b - CFO 5.98b) / TA 29.9b) |
| Beneish M = -3.08 (Cap -4..+1) = AA |
As of May 24, 2026, the stock is trading at USD 94.15 with a total of 1,944,437 shares traded.
Over the past week, the price has changed by +5.33%,
over one month by -2.27%,
over three months by -11.50% and
over the past year by +8.04%.
Coca-Cola European Partners has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CCEP.
- StrongBuy: 7
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 104.7 | 11.2% |
P/E Trailing = 17.9078
P/E Forward = 18.2815
P/S = 1.893
P/B = 4.5483
P/EG = 2.694
Revenue TTM = 41.3b EUR
EBIT TTM = 5.39b EUR
EBITDA TTM = 6.67b EUR
Long Term Debt = 9.69b EUR (from longTermDebt, last quarter)
Short Term Debt = 470.0m EUR (from shortTermDebt, last quarter)
Debt = 11.5b EUR (from shortLongTermDebtTotal, last quarter) + Leases 699.0m
Net Debt = 10.5b EUR (calculated: Debt 11.5b - CCE 972.0m)
Enterprise Value = 44.5b EUR (34.0b + Debt 11.5b - CCE 972.0m)
Interest Coverage Ratio = 10.52 (Ebit TTM 5.39b / Interest Expense TTM 512.7m)
EV/FCF = 10.07x (Enterprise Value 44.5b / FCF TTM 4.42b)
FCF Yield = 9.93% (FCF TTM 4.42b / Enterprise Value 44.5b)
FCF Margin = 10.70% (FCF TTM 4.42b / Revenue TTM 41.3b)
Net Margin = 8.13% (Net Income TTM 3.36b / Revenue TTM 41.3b)
Gross Margin = 35.61% ((Revenue TTM 41.3b - Cost of Revenue TTM 26.6b) / Revenue TTM)
Gross Margin QoQ = 35.81% (prev 35.34%)
Tobins Q-Ratio = 1.49 (Enterprise Value 44.5b / Total Assets 29.9b)
Interest Expense / Debt = 4.46% (Interest Expense 512.7m / Debt 11.5b)
Taxrate = 20.40% (267.0m / 1.31b)
NOPAT = 4.29b (EBIT 5.39b * (1 - 20.40%))
Current Ratio = 0.80 (Total Current Assets 6.08b / Total Current Liabilities 7.58b)
Debt / Equity = 1.47 (Debt 11.5b / totalStockholderEquity, last quarter 7.83b)
Debt / EBITDA = 1.58 (Net Debt 10.5b / EBITDA 6.67b)
Debt / FCF = 2.38 (Net Debt 10.5b / FCF TTM 4.42b)
Total Stockholder Equity = 8.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.37% (Net Income 3.36b / Total Assets 29.9b)
RoE = 40.88% (Net Income TTM 3.36b / Total Stockholder Equity 8.22b)
RoCE = 30.12% (EBIT 5.39b / Capital Employed (Equity 8.22b + L.T.Debt 9.69b))
RoIC = 18.87% (NOPAT 4.29b / Invested Capital 22.8b)
WACC = 5.96% (E(34.0b)/V(45.5b) * Re(6.78%) + D(11.5b)/V(45.5b) * Rd(4.46%) * (1-Tc(0.20)))
Discount Rate = 6.78% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 33.86 | Cagr: -0.87%
[DCF] Terminal Value 77.97% ; FCFF base≈3.40b ; Y1≈3.90b ; Y5≈5.74b
[DCF] Fair Price = 171.2 (EV 86.3b - Net Debt 10.5b = Equity 75.8b / Shares 442.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -34.77 | EPS CAGR: -15.18% | SUE: 0.0 | # QB: 0
Revenue Correlation: 95.99 | Revenue CAGR: 26.64% | SUE: -0.02 | # QB: 0
EPS current Year (2026-12-31): EPS=4.46 | Chg30d=+0.14% | Revisions=+25% | GrowthEPS=+4.2% | GrowthRev=+2.8%
EPS next Year (2027-12-31): EPS=4.88 | Chg30d=+0.00% | Revisions=-9% | GrowthEPS=+9.4% | GrowthRev=+3.7%
[Analyst] Revisions Ratio: +25%